All News
|
Research Feature
Cardiovascular disease remains the leading cause of death worldwide. This is why Nicole Redmond, M.D., Ph.D., M.P.H., chief of the Clinical Applications and Prevention branch in NHLBI’s Division of Cardiovascular Sciences, is bringing attention to silent pieces of information, like elevated blood pressure or cholesterol. When they go unchecked...
Showing 10 out of 2099 results
|
Media Advisory
What Leaders from the National Institutes of Health and partner organizations outline NIH’s COVID-19 research response in a policy forum in the journal Science. The authors also reflect on crucial lessons learned that will inform the public health research response to future pandemics. The authors emphasize that by building on decades of basic and...
|
Research Feature
Cardiovascular disease remains the leading cause of death worldwide. This is why Nicole Redmond, M.D., Ph.D., M.P.H., chief of the Clinical Applications and Prevention branch in NHLBI’s Division of Cardiovascular Sciences, is bringing attention to silent pieces of information, like elevated blood pressure or cholesterol. When they go unchecked...
|
News Release
Large NIH-supported study showed that rural-dwelling Black men are at greatest risk Adults living in rural areas of the United States have a 19% higher risk of developing heart failure compared to their urban counterparts, and Black men living in rural areas have an especially higher risk – 34%, according to a large observational study supported by...
|
Statement
Findings from a randomized, non-blinded, phase 3 clinical trial supported by the National Institutes of Health found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies for sepsis. The findings were published in the New England Journal of Medicine and were...
|
News Release
NIH-funded clinical trial underscores need for better treatments for deadly condition Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The...
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces new director of its Division of Blood Diseases and Resources WHO: Julie Panepinto, M.D., MSPH WHEN: Dr. Panepinto will start her new NHLBI position on January 15, 2023. WHERE: NHLBI of the National Institutes of Health BRIEF BIOGRAPHY: Dr. Julie Panepinto, a pediatric...
|
NHLBI in the Press
NIH findings link optimal fluid levels with reduced associated risks for advanced biological aging and premature death.
|
NHLBI in the Press
Following a healthy eating pattern is linked to a lower risk of death in general and a lower risk of death from heart disease, cancer, lung disease, and neurodegenerative disease.
|
News Release
NIH-supported study finds no serious complications following rare immune condition A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence. About half of participants experienced...
|
Media Availability
WHAT: Two National Institute of Health-supported diets, Dietary Approaches to Stop Hypertension (DASH) and Therapeutic Lifestyle Changes (TLC), together earned five No. 1 spots in U.S. News & World Report’s 2023 “Best Diets” rankings. The National Heart, Lung, and Blood Institute (NHLBI), part of NIH, researched, developed and tested both diets. Of...